D
David E. Price
Researcher at Carolinas Healthcare System
Publications - 13
Citations - 341
David E. Price is an academic researcher from Carolinas Healthcare System. The author has contributed to research in topics: Athletes & Population. The author has an hindex of 8, co-authored 13 publications receiving 277 citations. Previous affiliations of David E. Price include Carolinas Medical Center.
Papers
More filters
Journal ArticleDOI
AMSSM Position Statement on Cardiovascular Preparticipation Screening in Athletes: current evidence, knowledge gaps, recommendations and future directions
Jonathan A. Drezner,Francis G. O'Connor,Kimberly G. Harmon,Karl B. Fields,Chad A. Asplund,Irfan M. Asif,David E. Price,Robert J. Dimeff,David T. Bernhardt,William O. Roberts +9 more
TL;DR: It is the individual physician's assessment in the context of an emerging evidence base that the chosen model for early detection of cardiac disorders in the specific population provides greater benefit than harm.
Journal ArticleDOI
Electrocardiography-inclusive screening strategies for detection of cardiovascular abnormalities in high school athletes
David E. Price,Andrew McWilliams,Irfan M. Asif,Anthony Martin,Spencer D. Elliott,Michael Dulin,Jonathan A. Drezner +6 more
TL;DR: ECG adds value to PPS through increased detection of arrhythmogenic and structural cardiovascular conditions associated with sudden cardiac death through use of modern ECG interpretation standards allows a low false-positive rate.
Journal ArticleDOI
Stages of psychological impact after diagnosis with serious or potentially lethal cardiac disease in young competitive athletes: A new model
Irfan M. Asif,David E. Price,Leslee A. Fisher,Rebecca A. Zakrajsek,Leslie K. Larsen,Johannes Raabe,Matthew P. Bejar,Ashwin L. Rao,Kimberly G. Harmon,Jonathan A. Drezner +9 more
TL;DR: This proposed model of psychological impact should be used to develop improved support mechanisms, awareness, and education to assist athletes diagnosed with serious or potentially lethal cardiac disease.
Journal ArticleDOI
AMSSM Position Statement on Cardiovascular Preparticipation Screening in Athletes: Current Evidence, Knowledge Gaps, Recommendations, and Future Directions.
Jonathan A. Drezner,Francis G. O'Connor,Kimberly G. Harmon,Karl B. Fields,Chad A. Asplund,Irfan M. Asif,David E. Price,Robert J. Dimeff,David T. Bernhardt,William O. Roberts +9 more
TL;DR: The absence of definitive outcomes-based evidence at this time precludes AMSSM from endorsing any single or universal CV screening strategy for all athletes including legislative mandates, and this statement presents a new paradigm to assist the individual physician in assessing the most appropriateCV screening strategy unique to their athlete population, community needs, and resources.
Journal ArticleDOI
The impact of diagnosis: measuring the psychological response to being diagnosed with serious or potentially lethal cardiac disease in young competitive athletes
Irfan M. Asif,David E. Price,Alex Ewing,Ashwin L. Rao,Kimberly G. Harmon,Jonathan A. Drezner +5 more
TL;DR: Athletes diagnosed with potentially lethal cardiac disorders are at risk for significant psychological distress and should be offered consistent emotional support to mitigate psychological morbidity.